Patient-reported treatment burden of chronic immune thrombocytopenia therapies. - Wikidata - wikimedia - TriplyDB

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

http://www.wikidata.org/entity/Q33400348

about

Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia.Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial Eltrombopag-based combination treatment for immune thrombocytopenia

P2860

Q33419763-702DFC83-6739-4D77-B30B-2028B9D5B2A4 Q33431970-0A51B402-F9E5-4065-A9EE-892F93C05A13 Q40040235-D47A6395-0648-4A3C-A895-2D970A5D7585 Q52562217-E37A7C24-EFA9-4920-A12B-F1A3F965399C Q52633900-022DD10A-2683-4190-8030-8B82D7CD5867 Q57811987-88F758A7-346F-4CE6-85E6-0536E964EB82 Q57818187-7885A667-0751-444C-8BB9-0F276D4AC951

P2860

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

http://www.wikidata.org/entity/Q33400348

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@ast

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@en

type

label

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@ast

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@en

prefLabel

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@ast

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@en

P1433

Q33400348-15E625F2-DD8C-4FDB-BEFC-CF2B39A5077E

P1476

Q33400348-7076857A-CB14-4C55-9D0E-3BFC9CFB0471

P2093

Q33400348-044B6095-35A9-424D-BF78-9D69B454BCAA

Q33400348-5D220FB9-A2D3-409B-98D6-FE2BD7A216B4

Q33400348-73F3CFA2-C387-4E2B-AC01-DCDE7C360B8E

Q33400348-AC451355-283D-4EA8-A818-83B58DA5118A

Q33400348-ADEBCA4F-8DD4-4087-AC30-9CAED6010F26

P2860

Q33400348-073D22B7-4266-4B8B-A029-433E7579D1F4

Q33400348-09E852DF-53DF-400E-942E-B6EC9538AE56

Q33400348-200DDA75-9CC0-4A60-981C-C9E6DF229D05

Q33400348-234D1C99-5FEF-4331-B216-21600946DA47

Q33400348-2945A89B-437A-44E8-8910-FAA847A4AE9B

Q33400348-29A9623A-83D9-4B6E-B37E-8531DD58A950

Q33400348-2FEF538F-D631-4D35-AB4C-B553722CB8E2

Q33400348-3EABAEAC-5285-467E-945E-86C24B3415E0

Q33400348-4B820617-452A-46C4-A2D2-7B1557CA27BB

Q33400348-528D35FD-926F-4527-B9AD-A31B2B34FD4C

P2888

Q33400348-8AC6DC5D-869F-4EE2-8B06-D2D0D1FD4F2A

P304

Q33400348-20022275-00AD-4F90-8040-39EC2B9940FD

P31

Q33400348-CA60D096-BB96-4C9D-B602-B8E6EDD2A825

P356

Q33400348-C6A1C2B0-B1F5-4476-957D-AFE6B8AD500C

P478

Q33400348-56ECCFE0-7E93-4604-AFBC-A275891C1F67

P577

Q33400348-BD27BCB2-352A-4BDE-8FD8-EC845B33C04E

P5875

Q33400348-E84FACAD-9700-4E6E-92DD-64ED188AEF10

P6179

Q33400348-C6A62A08-C4CB-4E30-B243-DF277CEB81C8

P698

Q33400348-8D1BF200-24F8-4487-AFD4-E3B0DC768A10

P921

Q33400348-48629CD5-7512-41E9-BAF6-98B01432193F

P932

Q33400348-134EAC80-5062-4716-95CC-5FEA52BBAEAB

P356

P1433

BMC Blood Disorders

P1476

Patient-reported treatment burden of chronic immune thrombocytopenia therapies.

@en

P2093

Axel C Matzdorff

http://www.w3.org/2001/XMLSchema#string

Chris L Pashos

http://www.w3.org/2001/XMLSchema#string

Kelly M Grotzinger

http://www.w3.org/2001/XMLSchema#string

Ruslan V Horblyuk

http://www.w3.org/2001/XMLSchema#string

T Michelle Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of immune thrombocytopenia: analyses of administrative data.

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts.

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial.

Immune thrombocytopenic purpura.

Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses.

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

P2888

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2326-12-2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221902743

http://www.w3.org/2001/XMLSchema#string

P6179

1008511539

http://www.w3.org/2001/XMLSchema#string

P698

22436142

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

3350461

http://www.w3.org/2001/XMLSchema#string